Healthcare -
Medical - Devices - NYSE - US
$ 345.34
-0.133 %
$ 132 B
Market Cap
44.56
P/E
1. INTRINSIC VALUE
Balance Sheet
Stryker Corporation
| Current Assets | 14.8 B |
| Cash & Short-Term Investments | 4.4 B |
| Receivables | 3.99 B |
| Other Current Assets | 6.46 B |
| Non-Current Assets | 28.1 B |
| Long-Term Investments | 0 |
| PP&E | 3.45 B |
| Other Non-Current Assets | 24.7 B |
| Current Liabilities | 7.62 B |
| Accounts Payable | 1.68 B |
| Short-Term Debt | 1.41 B |
| Other Current Liabilities | 4.53 B |
| Non-Current Liabilities | 14.7 B |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 14.7 B |
EFFICIENCY
Earnings Waterfall
Stryker Corporation
| Revenue | 22.6 B |
| Cost Of Revenue | 8.16 B |
| Gross Profit | 14.4 B |
| Operating Expenses | 10.8 B |
| Operating Income | 3.69 B |
| Other Expenses | 696 M |
| Net Income | 2.99 B |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Stryker Corporation
| Net Income | 2.99 B |
| Depreciation & Amortization | 1.05 B |
| Capital Expenditures | -755 M |
| Stock-Based Compensation | 229 M |
| Change in Working Capital | 0 |
| Others | 340 M |
| Free Cash Flow | 3.49 B |
Wall Street Analysts Price Targets
Stryker Corporation
Wall Street analysts predict an average 1-year price target for SYK of $394 , with forecasts ranging from
a
low of
$345 to a high of $450 .
SYK Lowest Price Target
Wall Street Target
345 USD
-0.10%
SYK Average Price Target
Wall Street Target
394 USD
14.19%
SYK Highest Price Target
Wall Street Target
450 USD
30.31%
4. DIVIDEND
ANALYSIS
0.22%
DIVIDEND YIELD
0.84 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
Stryker Corporation
Sold
0-3 MONTHS
154 M USD 2
3-6 MONTHS
106 M USD 3
6-9 MONTHS
71.8 M USD 4
9-12 MONTHS
3.94 M USD 2
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC
VB Spine is a Strategic Partner to Stryker with Access to Mako Spine and Copilot Marc, John and Anthony Viscogliosi Lead VB Spine as Co-Chief Executive Officers NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Viscogliosi Brothers, LLC, a family-owned investment office specializing in the neuro-musculoskeletal space, today announced the successful completion of its previously announced acquisition of the U.S. spine business from Stryker (NYSE: SYK). The business will operate as a standalone company under the name VB Spine, LLC (“VB Spine”).
globenewswire.com
- 2 weeks ago
Stryker completes sale of U.S. spinal implants business
Portage, Michigan, April 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the sale of its U.S. spinal implants business to Viscogliosi Brothers, LLC, as part of the newly formed company VB Spine, LLC.
globenewswire.com
- 2 weeks ago
Stryker announces intention to nominate Manny Maceda to board of directors
Portage, Michigan, March 26, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its board of directors has nominated Emmanuel “Manny” Maceda for election to the company's board at the 2025 Annual Meeting of Shareholders, scheduled for May 8, 2025.
globenewswire.com
- 3 weeks ago
Stryker announces Annual Meeting of Shareholders
Portage, Michigan, March 25, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced its 2025 Annual Meeting of Shareholders is scheduled as follows:
globenewswire.com
- 3 weeks ago
3 Tariff-Proof Medical Device Stocks to Watch Amid Trump's MAGA Slogan
Tariffs are shaking up the Medical Device industry, but SYK, MDT & PODD are poised to thrive. Here's why three key players remain strong despite rising trade tensions.
zacks.com
- 1 month ago
Stryker Unveils Next-Generation Mako SmartRobotics but Stock Falls
SYK unveils next-gen Mako SmartRobotics, revolutionizing hip, knee and spine surgeries with greater precision and first-to-market robotic hip revision technology.
zacks.com
- 1 month ago
Stryker showcases next generation of Mako SmartRobotics™ at AAOS 2025 Annual Meeting
Latest technology offers more applications and innovation across more specialties MAHWAH, N.J. , March 11, 2025 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, showcases the latest advancements in Mako SmartRobotics™ across hip, knee, spine and shoulder procedures at the American Academy of Orthopaedic Surgeons' (AAOS) 2025 Annual Meeting in San Diego.
prnewswire.com
- 1 month ago
Inari Medical, now part of Stryker, launches Artix™ Thrombectomy System, designed to address a broad spectrum of arterial thrombus cases
PORTAGE, Mich. , March 6, 2025 /PRNewswire/ -- Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its Artix Thrombectomy System.
prnewswire.com
- 1 month ago
SYK Stock Declines Despite Steri-Shield Launch to Boost OR Portfolio
Stryker launches Steri-Shield 8, a cutting-edge PPE system with enhanced fit, visibility and protection, reinforcing its leadership in medical safety.
zacks.com
- 1 month ago
SYK Stock Gains on Launch of Hands-Free Device: Sync Badge
Stryker's Sunc Badge is a Hands-free, wearable communication device that will support care team members with fast and reliable collaboration. It is likely to help offset the ongoing nurse shortage.
zacks.com
- 1 month ago
Stryker launches Steri-Shield 8 personal protection system
Latest personal protection system offers customizable helmet and three toga choices PORTAGE, Mich. , March 4, 2025 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced the launch of its Steri-Shield 8 personal protection system, the latest in its personal protective equipment (PPE).
prnewswire.com
- 1 month ago
Stryker launches Sync Badge
Hands-free, wearable communication device supports care team members with fast and reliable collaboration PORTAGE, Mich. , March 3, 2025 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced the launch of the Sync Badge, a hands-free, wearable device designed to enhance communication and collaboration in the fast-paced environment of hands-on patient care.
prnewswire.com
- 1 month ago
8. Profile
Summary
Stryker Corporation SYK
COUNTRY
US
INDUSTRY
Medical - Devices
MARKET CAP
$ 132 B
Dividend Yield
0.22%
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Contact
2825 Airview Boulevard, Kalamazoo, MI, 49002
https://www.stryker.com
IPO
Date
March 17, 1980
Employees
53000
Officers
Mr. Alan Douville
Vice President, Chief Information Officer & Chief Information Security Officer
Mr. Viju S. Menon
Group President of Global Quality & Operations
Mr. Robert S. Fletcher
Vice President & Chief Legal Officer
Mr. Spencer S. Stiles
Group President of Orthopaedics & Spine
Mr. Kevin A. Lobo
Chairman, Chief Executive Officer & President
Mr. J. Andrew Pierce
Group President of MedSurg & Neurotechnology
Mr. William E. Berry Jr.
Vice President & Chief Accounting Officer
Mr. Robert C. Cohen
Chief Technology Officer and Vice President of Global R&D - Joint Replacement
Mr. Jason Beach
Vice President of Finance & Investor Relations
Ms. Dana S. McMahon
Vice President & Chief Compliance Officer